Latest Manufacturing News

Amaero has completed a A$22 million institutional placement, concluding nearly A$100 million raised since 2022 and positioning itself for commercialisation in FY2026 with a robust balance sheet.

SomnoMed Limited prepares to unveil its H1FY25 financial results on February 28, 2025, accompanied by a live investor presentation and Q&A session. The company remains a global leader in sleep apnea treatment solutions.

Breville Group Limited delivered a robust first half for FY25, posting double-digit revenue growth and a significant rise in net profit, underpinned by strong consumer demand and proactive inventory management to counter tariff risks.

Vulcan Steel Limited has announced a fully franked ordinary dividend of NZD 0.02588235 per share for the six months ending December 2024, payable on March 27, 2025. The dividend includes a supplementary component for Australian shareholders.

Queste Communications Ltd reported a robust $4.2 million net cash increase in January 2025, driven primarily by positive operating cash flows and strategic investing activities. The company’s consolidated cash position benefits from its controlling stake in Orion Equities Limited.

Merchant House International Limited has sold equipment from its shuttered American Merchant Inc textile factory for US$4 million, crystallising a significant A$9.02 million loss. The company continues to seek buyers for the remaining land and buildings.

Yowie Group Ltd has called in its loan facility with Keybridge Capital Limited following Keybridge's appointment of a Voluntary Administrator, prompting Yowie to explore new capital solutions amid recovery uncertainties.

Mayur Resources has locked in $11.2 million in funding from Pacific Unison to kickstart production at its Orokolo Bay Industrial Sands Project in Papua New Guinea, targeting 500,000 tonnes of magnetite annually by late 2025.

BTC Health has transformed its decade-long license agreement with Arna Pharma into an indefinite partnership, gaining royalties from Singapore and Malaysia sales and first rights to new pharmaceutical products in Australia and New Zealand.

Nanoveu Limited has completed the strategic acquisition of Embedded A.I. Systems Pte. Ltd. (EMASS), positioning itself at the forefront of ultra-low-power AI-driven edge semiconductor solutions. This move aims to enhance its EyeFly3D™ platform and expand into rapidly growing markets such as wearables, IoT, and autonomous devices.

VIP Gloves Limited has obtained a short-term interest-free loan of approximately AUD$1 million ahead of a planned share placement, as it faces potential delisting from the ASX pending a critical reinstatement decision.

PYC Therapeutics has secured regulatory approval to initiate human trials of PYC-003, a novel drug candidate targeting the root cause of Polycystic Kidney Disease (PKD). Initial safety and efficacy data are expected within 2025, marking a critical step in addressing a disease affecting millions worldwide.